drugset / Trial / NCT00028782
EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
This phase II trial is studying how well EF5 works in detecting oxygen level and blood vessels in tumor cells of patients who are undergoing photodynamic therapy for intraperitoneal or pleural cancer. Diagnostic procedures using EF5 to detect oxygen level and blood vessels in tumor cells may help to improve the way photodynamic therapy is given
Timeline
- Start
- 2001-10
- Primary completion
- 2007-09
- Completion
- —
Outcome
Outcome not reported
Stopped: “Administratively complete.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | etanidazole | Small molecule | — | Intravenous |